Eli Lilly CEO said he believed the company could find “significant common cause” with the Trump administration, even if there ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

BMI has long been falling out of favor. When the American Medical Association urged downgrading BMI in 2023, it blamed its “racist exclusion” and “historical harm.” The group also recommended ...

We explore the MAHA movement and sobriety, and a shift to 'natural' birth control, while an opinion writer says it's possible ...

NIH policy asks companies seeking licenses to sell medical products invented with government research to submit plans for ...

A new major federal report says having more than seven drinks per week carries a 1 in 1,000 risk of dying from alcohol use.

The Office of the Inspector General reviewed the FDA’s use of accelerated approval for 24 drugs, ultimately finding issues ...

For the second time in less than a year, the FTC has released a highly critical report of pharmacy benefit managers, or PBMs.

The latest edition of STAT’s Health Tech newsletter brings you important dispatches from the J.P. Morgan Health Care ...

Joe Edelman, a legendary biotech investor warns that shorting industry stocks isn’t easy. He has become a billionaire, anyway ...

At the JPM conference, Pfizer CEO Albert Bourla projected optimism, saying the market was overlooking the pharma company's ...

Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...